Seattle, WA, United States of America

Mark J Murray


 


Average Co-Inventor Count = 2.5

ph-index = 21

Forward Citations = 1,140(Granted Patents)


Location History:

  • Seattle, WA (US) (1988 - 1999)
  • King County, WA (US) (1988 - 2013)
  • Woodstock, IL (US) (2017)
  • Sugar Land, TX (US) (1998 - 2023)

Company Filing History:


Years Active: 1988-2024

Loading Chart...
Loading Chart...
Loading Chart...
42 patents (USPTO):Explore Patents

Title: **Mark J. Murray: Innovator in Blood Coagulation Protein Technologies**

Introduction

Mark J. Murray is a prominent inventor based in Seattle, WA, with an impressive track record of 22 patents. His work primarily focuses on the innovative development of proteins related to blood coagulation and wound healing, contributing significantly to advancements in biomedical science.

Latest Patents

Among his latest patents, Mark has been recognized for his groundbreaking work in the expression of Factor VII and IX activities in mammalian cells. This invention outlines methods for producing proteins that mediate blood coagulation via Factor VIIa or Factor IX, achieved through stable transfection of mammalian host cells with specific DNA constructs. These constructs contain nucleotide sequences that encode critical domains essential for the biological activity of these factors.

Additionally, Mark's patents include the development of biologically active PDGF A-chain homodimers. These dimeric proteins exhibit similar biological activity to PDGF and consist of two identical polypeptide chains that are substantially homologous to the A-chain of PDGF. His work also emphasizes therapeutic compositions using these proteins to enhance the wound-healing process in warm-blooded animals.

Career Highlights

Throughout his career, Mark has worked with companies such as Zymogenetics, Inc., where he has honed his expertise in biopharmaceutical innovations. His research and inventions have had a significant impact on the field of medicine, particularly in therapeutic applications related to blood coagulation.

Collaborations

In his journey, Mark has collaborated with notable colleagues, including James D. Kelly and Kathleen L. Berkner. These partnerships have likely contributed to the innovative successes he has achieved in his field.

Conclusion

Mark J. Murray's contributions to the development of crucial biomedical technologies demonstrate his commitment to innovation in the life sciences sector. With his extensive portfolio of patents, he continues to influence the landscape of medical research and therapeutic applications, particularly in blood coagulation and wound healing. His work serves as a testament to the impact that dedicated inventors can have on healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…